Top Key Companies for Multi-Organ Microfluidic Chip Market: CN Bio Innovations, Mimetas, Draper Laboratory, Kirkstall, Netri, Beijing Daxiang Biotech.
Global Multi-Organ Microfluidic Chip Market Size was estimated at USD 1645.73 million in 2022 and is projected to reach USD 2199.14 million by 2028, exhibiting a CAGR of 4.95% during the forecast period.
Global Multi-Organ Microfluidic Chip Market Overview And Scope:
The Global Multi-Organ Microfluidic Chip Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Multi-Organ Microfluidic Chip utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Multi-Organ Microfluidic Chip Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multi-Organ Microfluidic Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Multi-Organ Microfluidic Chip market.
Global Multi-Organ Microfluidic Chip Market Segmentation
By Type, Multi-Organ Microfluidic Chip market has been segmented into:
Gut/Liver-on-a-chip
Lung/Liver-on-a-chip
Nerve/Muscle-on-a-chip
Heart/Liver-on-a-chip
Others
By Application, Multi-Organ Microfluidic Chip market has been segmented into:
Pharmaceutical
Research Institute
Others
Regional Analysis of Multi-Organ Microfluidic Chip Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Multi-Organ Microfluidic Chip Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Multi-Organ Microfluidic Chip market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Multi-Organ Microfluidic Chip market.
Top Key Companies Covered in Multi-Organ Microfluidic Chip market are:
CN Bio Innovations
Mimetas
Draper Laboratory
Kirkstall
Netri
Beijing Daxiang Biotech
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Multi-Organ Microfluidic Chip Market by Type
5.1 Multi-Organ Microfluidic Chip Market Overview Snapshot and Growth Engine
5.2 Multi-Organ Microfluidic Chip Market Overview
5.3 Gut/Liver-on-a-chip
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Gut/Liver-on-a-chip: Geographic Segmentation
5.4 Lung/Liver-on-a-chip
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Lung/Liver-on-a-chip: Geographic Segmentation
5.5 Nerve/Muscle-on-a-chip
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Nerve/Muscle-on-a-chip: Geographic Segmentation
5.6 Heart/Liver-on-a-chip
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Heart/Liver-on-a-chip: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
Chapter 6: Multi-Organ Microfluidic Chip Market by Application
6.1 Multi-Organ Microfluidic Chip Market Overview Snapshot and Growth Engine
6.2 Multi-Organ Microfluidic Chip Market Overview
6.3 Pharmaceutical
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Pharmaceutical: Geographic Segmentation
6.4 Research Institute
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Research Institute: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Multi-Organ Microfluidic Chip Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Multi-Organ Microfluidic Chip Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Multi-Organ Microfluidic Chip Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 CN BIO INNOVATIONS
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 MIMETAS
7.4 DRAPER LABORATORY
7.5 KIRKSTALL
7.6 NETRI
7.7 BEIJING DAXIANG BIOTECH
Chapter 8: Global Multi-Organ Microfluidic Chip Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Gut/Liver-on-a-chip
8.2.2 Lung/Liver-on-a-chip
8.2.3 Nerve/Muscle-on-a-chip
8.2.4 Heart/Liver-on-a-chip
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Pharmaceutical
8.3.2 Research Institute
8.3.3 Others
Chapter 9: North America Multi-Organ Microfluidic Chip Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Gut/Liver-on-a-chip
9.4.2 Lung/Liver-on-a-chip
9.4.3 Nerve/Muscle-on-a-chip
9.4.4 Heart/Liver-on-a-chip
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Pharmaceutical
9.5.2 Research Institute
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Multi-Organ Microfluidic Chip Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Gut/Liver-on-a-chip
10.4.2 Lung/Liver-on-a-chip
10.4.3 Nerve/Muscle-on-a-chip
10.4.4 Heart/Liver-on-a-chip
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Pharmaceutical
10.5.2 Research Institute
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Multi-Organ Microfluidic Chip Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Gut/Liver-on-a-chip
11.4.2 Lung/Liver-on-a-chip
11.4.3 Nerve/Muscle-on-a-chip
11.4.4 Heart/Liver-on-a-chip
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Pharmaceutical
11.5.2 Research Institute
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Multi-Organ Microfluidic Chip Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Gut/Liver-on-a-chip
12.4.2 Lung/Liver-on-a-chip
12.4.3 Nerve/Muscle-on-a-chip
12.4.4 Heart/Liver-on-a-chip
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Pharmaceutical
12.5.2 Research Institute
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Multi-Organ Microfluidic Chip Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Gut/Liver-on-a-chip
13.4.2 Lung/Liver-on-a-chip
13.4.3 Nerve/Muscle-on-a-chip
13.4.4 Heart/Liver-on-a-chip
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Pharmaceutical
13.5.2 Research Institute
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Multi-Organ Microfluidic Chip Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Gut/Liver-on-a-chip
14.4.2 Lung/Liver-on-a-chip
14.4.3 Nerve/Muscle-on-a-chip
14.4.4 Heart/Liver-on-a-chip
14.4.5 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Pharmaceutical
14.5.2 Research Institute
14.5.3 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Multi-Organ Microfluidic Chip Scope:
|
Report Data
|
Multi-Organ Microfluidic Chip Market
|
|
Multi-Organ Microfluidic Chip Market Size in 2025
|
USD XX million
|
|
Multi-Organ Microfluidic Chip CAGR 2025 - 2032
|
XX%
|
|
Multi-Organ Microfluidic Chip Base Year
|
2024
|
|
Multi-Organ Microfluidic Chip Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
CN Bio Innovations, Mimetas, Draper Laboratory, Kirkstall, Netri, Beijing Daxiang Biotech.
|
|
Key Segments
|
By Type
Gut/Liver-on-a-chip
Lung/Liver-on-a-chip
Nerve/Muscle-on-a-chip
Heart/Liver-on-a-chip
Others
By Applications
Pharmaceutical
Research Institute
Others
|
